|
|
 |
C-Peptide | | | General Information | |
| Vendor | | Siemens Healthcare Diagnostics | | Item | | C-Peptide | | Catalog Number | | Inquire | | Size | | Inquire | | Range | | Inquire | | Sample Type | | Blood | | Regulatory Status | | Inquire | | Discipline | | Inquire | | Sensitivity | | Inquire | | Incubation Time | | Inquire | | Pricing |  |  |
| | Product Description | |
| Insulin and C-peptide determinations are used for the differential diagnosis of hypoglycemia. Elevated levels raise the possibility of an insulin-producing tumor (insulinoma). C-peptide measurements may be used to distinguish between these two possibilities. Commercial insulin preparations do not contain C-peptide, which is therefore expected to be low in cases of exogenous insulin administration. In contrast, both C-peptide and insulin are released in equimolar amounts and both are expected to be elevated in cases of insulinoma.
| | Go to Vendor Product Page | | Go to Vendor Website | |
| Siemens Healthcare Diagnostics | | Customer Service: 800-242-3233 | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
